Catalyst Pharmaceutical Partners (CPRX)

[dough_maker]

Even if the 20 year part were true, that says nothing about how many people got the treatment through Jacobus. Was it 5 people, 10 people or 100 people? That would be important information. But it is conveniently overlooked as are other important pieces of information (such as what Jacobus is doing to stop CPRX, what are the odds of success for them? etc. All of which would help investors measure the risk). That is why I say this article is just geared towards stirring up emotions.

BTW, AF doesn't say CPRX will fail in its bid. He has often made calls that are on point. If anything, he says odds of a successful study are high "If the Firdapse study is positive (high odds, see Europe), Catalyst plans to submit the drug for U.S. approval in 2015 and start selling it in 2016."